11. SEROLOGICAL RESPONSES AFTER SARS‐COV‐2 VACCINATION FIRST DOSE IN PATIENTS WITH LYMPHOID MALIGNANCY: FIRST INTERIM ANALYSIS OF THE UK PROSECO STUDY. (17th June 2021) Authors: Lim, S.H.; Campbell, N.; Joseph‐Pietras, D.; Johnson, M.; Mundy, C.; Coleman, H.; Wynn, T.; Maynard, B.; Lown, R.; Bates, A.; Wetherall, N.; Muller, D.; Falconer, J.; Fox, C.; Collins, G.; O'Callaghan, A.; Willimott, V.; Ahearne, M.; Faust, S.N.; Johnson, P.W. Journal: Hematological oncology Issue: Volume 39(2021)Supplement 2 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. TRANSCRIPTIONAL NETWORKS ASSOCIATED WITH TREATMENT FAILURE IN ADVANCED‐STAGE HODGKIN LYMPHOMA: DATA FROM THE RATHL TRIAL (CRUK/07/033). (12th June 2019) Authors: Lim, S.H.; Burton, C.; Barrans, S.; Kirkwood, A.; Patrick, P.; Stevens, L.; Clifton‐Hadley, L.; Johnson, P.W.; Thirdborough, S.M. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 293 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. YourTreatmentChoices: FAST ACCESS TO TRIALS PROGRAMME. (June 2017) Authors: Radford, J.; Gribben, J.; Johnson, P.W.; Malladi, R.; Neeson, S.; Asfaw, B.; O'Regan, L.; Law, A.; Ringrose, C.; Brownlow, R.; Jackson, A.; Nolan, C.; Nolan, C. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 272 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗